Julie Jordan Homology Medicines, Inc. (FIXX) insider trading activity

FIXX Quotes by TradingView

Julie Jordan is Chief Medical Officer of Homology Medicines, Inc.. Currently has a direct ownership of 7,496 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Aug 03, 2023, when has been sold 1,853 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $2,575. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.5K
0% 3M change
0% 12M change
Total Value Held $0

Julie Jordan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 03 2023
SELL
Open market or private sale
$2,575 $1.39 p/Share
1,853 Reduced 19.82%
7,496 Common Stock
Aug 03 2023
BUY
Exercise of conversion of derivative security
-
6,579 Added 42.77%
8,804 Common Stock
Aug 02 2023
SELL
Open market or private sale
$129 $1.31 p/Share
99 Reduced 3.45%
2,770 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
-
350 Added 10.87%
2,869 Common Stock

Also insider at

NLTX
Neoleukin Therapeutics, Inc. Healthcare
Chief Medical Officer
JJ

Julie Jordan

Chief Medical Officer
Bedford, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FIXX